Dissecting the Benefits and Challenges of Cell and Gene Therapies at the Global Conference

In CAR T-cell therapy, T cells are extracted from the patient's blood and altered in the laboratory by adding a gene for a receptor (known as a chimeric antigen receptor, or CAR), which aids the T cells in adhering to a particular cancer cell antigen. The patient is subsequently given their CAR T cells back. #CAR T-cell therapy #WORLD CELL THERAPY 2023 #Contact Info: genetherapy@euroconferences.net | +44 1303610264